Kura Oncology, Inc. (KURA)
9.12
-0.08
(-0.87%)
USD |
NASDAQ |
May 19, 13:33
Kura Oncology Research and Development Expense (Quarterly) : 65.26M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Curis, Inc. | 6.449M |
| Novavax, Inc. | 95.47M |
| Capricor Therapeutics, Inc. | 27.10M |
| Agenus, Inc. | 11.82M |
| LadRx Corp. | 0.0288M |